Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRM1 | P35372 | 1/20 | 0.67 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.67 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.67 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.62 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23114234 | 1.00 | OPRM1 (0.67) | OPRM1OPRD1OPRK1SLC6A2 | |
| SCHEMBL13118010 | 1.00 | OPRM1 (0.67) | OPRM1OPRD1OPRK1SLC6A2 | |
| SCHEMBL13563448 | 0.96 | OPRM1 (0.66) | OPRM1OPRD1OPRK1 | |
| SCHEMBL13563441 | 0.96 | OPRM1 (0.66) | OPRM1OPRD1OPRK1 | |
| SCHEMBL31347655 | 0.96 | OPRM1 (0.66) | OPRM1OPRD1OPRK1 | |
| SCHEMBL29037548 | 0.96 | OPRM1 (0.66) | OPRM1OPRD1OPRK1 | |
| SCHEMBL31519795 | 0.95 | OPRM1 (0.69) | OPRM1OPRD1OPRK1 | |
| Endomorphin 2 SCHEMBL13252092 | 0.91 | OPRM1 (0.76) | OPRM1OPRD1OPRK1 | |
| Endomorphin 2 SCHEMBL22649436 | 0.91 | OPRM1 (0.76) | OPRM1OPRD1OPRK1 | |
| Endomorphin 2 SCHEMBL29577635 | 0.91 | OPRM1 (0.76) | OPRM1OPRD1OPRK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 47 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025096781-A1 | METHODS AND COMPOSITIONS FOR PROVIDING CUSTOMIZED SKIN REGIMENS | VIBRANT HOLDINGS, LLC (US) | 2025-05-08 | — | — | WO | claimed |
| EP-3795146-B1 | PAIN-RELIEVING AND ANTI-INFLAMMATORY COMPOSITION FOR LOCAL USE | AQMA ITALIA S P A (IT) | 2023-06-07 | — | — | EP | claimed |
| CN-122056799-A | Sensitive muscle barrier repair composition and preparation method and application thereof | 青岛中科蓝智生物科技发展有限公司 | 2026-05-19 | — | — | CN | disclosed |
| WO-2026099555-A1 | COSMETIC USE OF AN EXTRACT OF LYSIMACHIA CHRISTINAE | BASF BEAUTY CARE SOLUTIONS FRANCE SAS (FR) | 2026-05-15 | — | — | WO | disclosed |
| EP-4340807-B1 | HAIR COLOR COMPOSITIONS FOR MITIGATING COLOR LOSS | LUBRIZOL ADVANCED MAT INC (US) | 2026-01-28 | — | — | EP | disclosed |
| US-20250352462-A1 | NOVEL COSMETIC OR DERMATOLOGICAL COMPOSITION CONTAINING A STRAIN OF LIVE PROBIOTIC BACTERIA | BASF BEAUTY CARE SOLUTIONS FRANCE SAS (FR) | 2025-11-20 | — | — | US | disclosed |
| WO-2025215143-A1 | LIPOSOMAL COMPOSITION FOR TOPICAL ADMINISTRATION | EVANIUM HEALTHCARE GMBH (DE) | 2025-10-16 | — | — | WO | disclosed |
| CN-120136961-A | Preparation method of acyl tetrapeptides | 深圳瑞德林生物技术有限公司 | 2025-06-13 | — | — | CN | disclosed |
| WO-2025096781-A1 | METHODS AND COMPOSITIONS FOR PROVIDING CUSTOMIZED SKIN REGIMENS | VIBRANT HOLDINGS, LLC (US) | 2025-05-08 | — | — | WO | disclosed |
| EP-4539819-A1 | NOVEL COSMETIC OR DERMATOLOGICAL COMPOSITION CONTAINING A STRAIN OF LIVE PROBIOTIC BACTERIA | BASF Beauty Care Solutions France SAS (FR) | 2025-04-23 | — | — | EP | disclosed |
| CN-119403540-A | Novel cosmetic or dermatological composition containing a strain of live probiotic bacteria | 巴斯夫美容护理法国公司 | 2025-02-07 | — | — | CN | disclosed |
| US-11234918-B2 | Methods for botanical and/or algae extraction | BASF CORPORATION (US) | 2022-02-01 | — | — | US | disclosed |
| EP-3795146-A1 | PAIN-RELIEVING AND ANTI-INFLAMMATORY COMPOSITION FOR LOCAL USE | Aqma Italia S.p.A. (IT) | 2021-03-24 | — | — | EP | disclosed |
| EP-3737352-A1 | COSMETIC USE OF A PROTEIN EXTRACT OF MORINGA OLEIFERA SEEDS | BASF Beauty Care Solutions France SAS (FR) | 2020-11-18 | — | — | EP | disclosed |
| US-20200330366-A1 | COSMETIC USE OF A PROTEIN EXTRACT OF MORINGA OLEIFERA SEEDS | BASF BEAUTY CARE SOLUTIONS FRANCE SAS (FR) | 2020-10-22 | — | — | US | disclosed |
| CN-111526864-A | Cosmetic use of protein extracts of moringa seeds | 巴斯夫美容护理法国公司 | 2020-08-11 | — | — | CN | disclosed |
| WO-2019008937-A1 | FOAMING CLEANSER | L'OREAL (FR) | 2019-01-10 | — | — | WO | disclosed |
| US-20160213599-A1 | COSMETIC COMPOSITION COMPRISING A SULFONIC POLYMER, A HYDROPHOBIC POLYSACCHARIDE AND SILICONE SURFACTANT | L'OREAL (FR) | 2016-07-28 | — | — | US | disclosed |
| EP-3038597-A2 | COSMETIC COMPOSITION COMPRISING A SULPHONIC POLYMER, A HYDROPHOBIC POLYSACCHARIDE AND A SILICONE SURFACTANT | L'OREAL (FR) | 2016-07-06 | — | — | EP | disclosed |
| EP-2238966-A2 | Scalp-protecting shampoos and conditioners | Henkel AG & Co. KGaA (DE) | 2010-10-13 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11234918-B2 | Methods for botanical and/or algae extraction | ALG1, ALG8, CUTA | OPRM1 4824/4885OPRD1 4806/4885OPRK1 4769/4885 |
| US-20160213599-A1 | COSMETIC COMPOSITION COMPRISING A SULFONIC POLYMER, A HYDROPHOBIC POLYSACCHARIDE AND SILICONE SURFACTANT | MUC1, SMURF1, KRT18 | OPRM1 3003/4885OPRD1 2761/4885OPRK1 3492/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.